For the symptomatic relief of pain and irritation associated with haemorrhoids.

Route of administration: For rectal administration.

Adults and the elderly.

If necessary empty the bowels before using the suppository. Remove the protective film and insert the suppository as deep as possible into the rectum. One suppository should be inserted night and morning after each bowel movement. Do not use for more than 7 days unless advised by your doctor.

Children.

Not recommended for children.

Hypersensitivity to any of the ingredients, especially lidocaine.

Anodesyn Suppositories / Boots Haemorrhoid Suppositories /Sainsburys Haemorrhoid Relief Suppositories are intended for use for short periods and should not be used for longer than 7 days without medical advice. Patients should be instructed to seek medical advice if they experience persistent pain or bleeding from the anus, especially where associated with a change in bowel habit, if the stomach is distended or if they are losing weight.

The label will state:

Keep all medicines out of the reach and sight of children.

If symptoms persist for more than 7 days consult your doctor.

No clinically significant drug interactions known.

The safety of Anodesyn Suppositories/Boots Haemorrhoid Suppositories /Sainsburys Haemorrhoid Relief Suppositories in pregnancy and lactation has not been established, but it is thought unlikely to constitute a hazard, though caution should be exercised during the first trimester.

Lidocaine crosses the placenta and is distributed into breast milk.

No or negligible influence.

Hypersensitivity to any of the ingredients, particularly lidocaine. Occasionally may cause diarrhoea.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

Accidental ingestion may result in anaesthesia of the upper respiratory tract, nausea, vomiting and abdominal discomfort. Ingestion of very large quantities could result in CNS and cardiovascular toxicity.

Treatment should be symptomatic and supportive.

C05A D0l - Products containing local anaesthetics

Lidocaine has a local anaesthetic action, relieving pain and discomfort in the affected areas. Allantoin is claimed to promote healing.

Not applicable

There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.

Colloidal Anhydrous Silica

Witepsol W35

Purified Water

Not applicable

Three years.

Store at or below 25° C.

A white polythene lined, unplasticised PVC moulded strip, heat sealed and placed into a printed carton, containing 6, 12 or 24 suppositories.

None stated.